MARCAINE Drug Patent Profile
Which patents cover Marcaine, and when can generic versions of Marcaine launch?
Marcaine is a drug marketed by Hospira and is included in two NDAs.
The generic ingredient in MARCAINE is bupivacaine hydrochloride; epinephrine bitartrate. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MARCAINE?
- What are the global sales for MARCAINE?
- What is Average Wholesale Price for MARCAINE?
Summary for MARCAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 112 |
| Clinical Trials: | 295 |
| Patent Applications: | 1,011 |
| Drug Prices: | Drug price information for MARCAINE |
| What excipients (inactive ingredients) are in MARCAINE? | MARCAINE excipients list |
| DailyMed Link: | MARCAINE at DailyMed |
Recent Clinical Trials for MARCAINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Texas Scottish Rite Hospital for Children | PHASE2 |
| Mersin University | NA |
| University of Tennessee | PHASE4 |
Pharmacology for MARCAINE
| Drug Class | Amide Local Anesthetic |
| Physiological Effect | Local Anesthesia |


